SCHEMBL21169331

SCHEMBL21169331

C1C[C@@H]2C[C@H]3[C@@H](C2)C2(OCCO2)[C@H]3C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23369742 0.88
SCHEMBL23080516 0.88
SCHEMBL21621805 0.88
SCHEMBL23080515 0.88
SCHEMBL19982473 0.88
SCHEMBL24631081 0.88
SCHEMBL19982472 0.88
SCHEMBL21169319 0.60 HSD17B10 (0.37)
SCHEMBL20859129 0.60
SCHEMBL19309630 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10654794-B2 Fused tricyclic Γ-amino acid derivative, preparation method therefor, and medical use thereof SICHUAN HAISO PHARMACEUTICAL CO., LTD. (CN) 2020-05-19 US disclosed
US-20190218172-A1 FUSED TRICYCLIC GAMMA-AMINO ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF SICHUAN HAISO PHARMACEUTICAL CO., LTD. (CN) 2019-07-18 US disclosed